Sponsor

International Maternal Pediatric Adolescent AIDS Clinical Trials Group

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name International Maternal Pediatric Adolescent AIDS Clinical Trials Group appears in 34 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials34
Recruiting shown1
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

34 shown
Understanding Practices of Lactation and Infant Feeding Together With Women With HIV in the United StatesNCT07293559 · lead sponsor · 2026-02-24
RECRUITING
Safety and Immunogenicity of VPM1002 Vaccination or BCG Revaccination Against TB in Pre-Adolescents Living With and Without HIV in South AfricaNCT05539989 · lead sponsor · 2026-12-31
WITHDRAWN
Cabotegravir & Rilpivirine Antiretroviral Therapy in PregnancyNCT07637942 · lead sponsor · 2026-10-15
NOT_YET_RECRUITING
Group-Based Intervention to Improve Mental Health and Adherence Among Youth Living With HIV in Low Resource SettingsNCT04024488 · lead sponsor · 2024-04-06
TERMINATED
Long-Term Clinical, Immunologic, and Virologic Profiles of Children Who Received Early Treatment for HIVNCT05154513 · lead sponsor · 2022-02-02
COMPLETED
IMPAACT 2015 - Evaluation of the HIV-1 Reservoir in the Central Nervous System of Perinatally-Infected Youth and Young Adults With Cognitive ImpairmentNCT03416790 · lead sponsor · 2019-02-06
COMPLETED
IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIVNCT02939131 · lead sponsor · 2017-03-06
COMPLETED
IMPAACT P1092: Steady State PK in Malnourished HIV Infected ChildrenNCT01818258 · lead sponsor · 2015-10-26
COMPLETED
IMPAACT P1106: Pharmacokinetic Characteristics of Antiretrovirals and Tuberculosis Medicines in Low Birth Weight InfantsNCT02383849 · lead sponsor · 2015-08-04
COMPLETED
IMPAACT P1107: Effects of Cord Blood Transplantation With CCR5Δ32 Donor Cells on HIV PersistenceNCT02140944 · lead sponsor · 2015-02-05
COMPLETED
Pharmacology of Antimalarial Therapy With or Without Antiretroviral TherapyNCT01728961 · lead sponsor · 2012-02-01
TERMINATED
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging StrategyNCT01338025 · lead sponsor · 2011-03-01
TERMINATED
IMPAACT P1073: Study of IRIS for Infants and Children Initiating HAART at Int'l SitesNCT01240486 · lead sponsor · 2010-11-01
COMPLETED
IMPAACT P1080: Psychiatric and Antiretroviral Medication Concentrations in HIV-infected and Uninfected Children and AdolescentsNCT01232361 · lead sponsor · 2010-10-08
COMPLETED
IMPAACT 1077HS: Examining Benefits of HAART Continuation in Postpartum WomenNCT00955968 · lead sponsor · 2010-01-01
COMPLETED
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With HyperlipidemiaNCT00663234 · lead sponsor · 2009-08-01
TERMINATED
Differences in Malaria Infection Levels in HIV-infected Infants and Children Receiving PI- and NNRTI-based HAARTNCT00719602 · lead sponsor · 2009-08-01
COMPLETED
IMPAACT P1074: Long-Term Outcomes in HIV-Infected Infants, Children, and AdolescentsNCT01061164 · lead sponsor · 2009-03-01
COMPLETED
Antiviral Responses to NNRTI-Based vs. PI-Based ARV Therapy in HIV Infected Infants Who Have or Have Not Received Single Dose NVP for Prevention of Mother-to-Child Transmission of HIVNCT00307151 · lead sponsor · 2005-12-01
COMPLETED
Psychiatric Problems in Children and Adolescents Infected With HIV at BirthNCT00100542 · lead sponsor · 2005-04-01
COMPLETED
Daily Isoniazid to Prevent Tuberculosis in Infants Born to Mothers With HIVNCT00080119 · lead sponsor · 2004-02-01
TERMINATED
Prenatal and Postnatal Studies of Interventions for Prevention of Mother-To-Child TransmissionNCT00028145 · lead sponsor · 2002-10-01
COMPLETED
IMPAACT P1058A: Pharmacokinetic Effects of New Antiretroviral Drugs on Children, Adolescents and Young AdultsNCT00977756 · lead sponsor · 2002-08-01
COMPLETED
Pharmacokinetic Properties of Antiretroviral and Anti-Tuberculosis Drugs During Pregnancy and PostpartumNCT04518228 · collaborator · 2021-09-01
TERMINATED
The Pharmacokinetics, Safety, and Tolerability of Abacavir/Dolutegravir/Lamivudine Dispersible and Immediate Release Tablets in HIV-1-Infected Children Less Than 12 Years of AgeNCT03760458 · collaborator · 2020-09-09
COMPLETED
Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed InfantsNCT01861730 · collaborator · 2013-07-01
COMPLETED
Single-dose Study to Assess Efficacy of Canakinumab (ACZ885) in Patients With Active Juvenile Idiopathic Arthritis (SJIA)NCT00886769 · collaborator · 2009-07-01
TERMINATED
Safety and Pharmacokinetic Study of Fixed Dose Combination of Zidovudine, Lamivudine, and Nevirapine in HIV-Infected Children in ThailandNCT00672412 · collaborator · 2008-10-01
COMPLETED
Preservation and Expansion of T-cell Subsets Following HAART De-intensification to Atazanavir/Ritonavir (ATV/r)NCT00491556 · collaborator · 2007-10-01
COMPLETED
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and YouthNCT00459316 · collaborator · 2007-06-01
COMPLETED
Drug Levels of Tablet and Liquid Forms of Lamivudine, Nevirapine, and Stavudine in HIV Infected Thai ChildrenNCT00312091 · collaborator · 2006-12-01
COMPLETED
Safety of Tenofovir Disoproxil Fumarate (TDF) and Emtricitabine/TDF in HIV Infected Pregnant Women and Their InfantsNCT00076791 · collaborator · 2004-03-01
COMPLETED
Atazanavir Used in Combination With Other Anti-HIV Drugs in HIV-Infected Infants, Children, and AdolescentsNCT00006604 · collaborator · 2000-11-01
COMPLETED
Safety and Tolerability of a Therapeutic DNA Dendritic Cell Vaccine in HIV-Infected Children, Adolescents, and Young AdultsNCT00614640 · collaborator
WITHDRAWN

Drugs studied in this sponsor's trials

9 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing International Maternal Pediatric Adolescent AIDS Clinical Trials Group as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
lamivudine4
nevirapine4
zidovudine3
ritonavir2
atorvastatin1
canakinumab1
cobicistat1
stavudine1
lamivudine RxCUI 68244 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 4 trials nevirapine RxCUI 53654 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 4 trials zidovudine RxCUI 11413 · Lead sponsor in 2 linked trial(s) · 0 currently recruiting 3 trials ritonavir RxCUI 85762 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 2 trials atorvastatin RxCUI 83367 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial canakinumab RxCUI 853491 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial cobicistat RxCUI 1306284 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial stavudine RxCUI 59763 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial tenofovir disoproxil fumarate RxCUI 322248 · Lead sponsor in 0 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor23
collaborator11
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.